To include your compound in the COVID-19 Resource Center, submit it here.

Telotristat etiprate: Phase II data

Top-line data from a double-blind, placebo-controlled, U.S. Phase II trial in 23 patients with refractory carcinoid syndrome showed that 5 patients

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE